Company Financial Calendar
| Event |
Date |
| Half year end |
30th June |
| Interim results announced |
September |
| Financial year end |
31st December |
| AGM |
TBD |
Company Financial Reports
Annual Report, 2008
Interim Financial Statements June 30, 2008
Annual Report 2007
Medgenics Admission Document December 2007
Regulatory Disclosures, Announcements and Notifications
June 22, 2009: Medgenics Closes First Series of Fund Raising
June 16, 2009: Resolutions Adopted by Shareholders
June 4, 2009:6 Month Block Listing Interim Review
May 22, 2009: Preliminary Results: Medgenics announces its preliminary results for the 12 months ended 31 Dec 2008
May 11, 2009: Medgenics requests Stockholder Action in connection with fund raising through the proposed issue of convertible debenturesl
Mar 27, 2009: Encouraging results of the Company’s ongoing EPODURE Biopump Phase I/II Clinical Tria
Feb 16, 2009: Directors’ Dealings
Feb 5, 2009: Medgenics Warrant repricing extension
Feb 03, 2009: Clinical Trial Update
Feb 03, 2009: Directors Dealing
Dec 17, 2008: Medgenics warrant repricing announcement
Dec 4, 2008: Issue of Options to Director
Dec 4, 2008: Six monthly Block statement
Nov. 12, 2008: 17% of Medgenics Common Shares Now Unrestricted Using New Ticker MEDU
Nov 3, 2008: Medgenics Preliminary Data: The landmark Phase I/II clinical trial of Medgenics’ EPODURE Biopump
Sept. 24, 2008: Interim Results - Half Yearly Report for the six month period ended June 30 2008
Sept. 23, 2008 Statement: Share Price Movement
July 30, 2008: Medgenics Granted Approval to Commence Its Phase I/II Clinical Study of EPODURE to treat Anemia
July 4, 2008: Response from ISRAEL’S Ministry of Health on its Phase I/II clincal Trial with EPODURE in Anemia
June 30, 2008: Notification of transactions of directors, persons discharging managerial responsibility or connected persons
June 30, 2008: Issue of Equity Total Voting Rights
June 19, 2008: Medgenics announces preliminary results for the year ended 31 December 2007
June 4, 2008: Block Listing Interim Review
May 7, 2008: Medgenics appoints vice president of Clinical Affairs
Apr 30, 2008: Total Voting Rights
Apr 22, 2008: Announcement re Issue of Equity
Apr 14, 2008: Research Update: Medgenics on target to start Phase I/II clinical trials with EPODURE protein therapy for anaemia mid-2008 as planned
Mar 18, 2008: Medgenics consolidates corporate and R&D operations into new office facility
Feb 1, 2008: Lord Steinberg Appointment
Dec 4, 2007: Medgenics Admission to Trading
Dec 4, 2007: Medgenics Block Admission and ISIN update
Preliminary Announcement of AIM Submission
|
|
